Published in Vaccine Weekly, May 14th, 2003
"The major treatments of malignant tumors of digestive tract postoperatively are radiotherapy and chemotherapy," said Wei Liang and collaborators at Liaoning Provincal Tumor Research Institute in China. "However, it is very difficult to improve the five-year survival rate. We treated these patients with autologous tumor cell vaccine and NDV vaccine and made a 7-year follow-up survey of postoperative patients with autologous tumor cell vaccine."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.